New medicines from nature's armamentarium

Area of Science:

• Drug Discovery and Development
• Infectious Diseases
• Natural Products Chemistry

Background:

• Emerging infectious diseases (e.g., HIV, SARS, Ebola, avian flu) pose significant global health threats.
• Endemic diseases like malaria and tuberculosis remain persistent challenges.
• Nature is a rich source of compounds for developing novel anti-infective therapies.

Purpose of the Study:

• To highlight recent advances in the discovery of anti-infective drugs from natural sources.
• To examine the development pathway of ivermectin as a model for drug development.
• To illustrate the establishment of public-private partnerships in drug discovery.

Main Methods:

• Review of recent scientific advances in natural product-derived anti-infectives.
• Case study analysis of ivermectin's development and regulatory pathway.
• Discussion of historical precedents in public-private collaborations for drug development.

Main Results:

• Several new advances in identifying natural anti-infective drug candidates were presented.
• The development of ivermectin showcased a successful, albeit challenging, drug discovery journey.
• Key precedents were established for public-private partnerships in pharmaceutical development.

Conclusions:

• Natural products remain a vital resource for combating infectious diseases.
• The ivermectin case study provides a valuable model for future drug development and public-private collaborations.
• Continued human ingenuity and strategic partnerships are essential for addressing global health challenges posed by pathogens.